Phosphoserine aminotransferase SerC is a central metabolic checkpoint and druggable vulnerability in Mycobacterium tuberculosis

This study identifies phosphoserine aminotransferase (SerC) as an essential metabolic checkpoint and promising drug target in *Mycobacterium tuberculosis*, demonstrating that its disruption severely impairs bacterial growth and intracellular survival by rewiring central carbon and nitrogen metabolism.

The Gist

The Big Picture: Finding a Weak Spot in the Enemy's Armor

Imagine Mycobacterium tuberculosis (Mtb) as a highly skilled burglar trying to break into a house (your body). This burglar is very good at hiding, stealing food, and surviving in tough conditions. The problem is that the burglar has become resistant to the old locks and alarms (antibiotics) we used to use, making it harder to stop them.

This paper is about scientists discovering a specific, critical "back door" in the burglar's plan that they can't seem to bypass. If you block this door, the burglar starves and dies, even if they have all the other tools they need.

The Main Character: The "Serine Chef" (SerC)

Inside the bacteria, there is a tiny machine called an enzyme named SerC. Think of SerC as the head chef in the bacteria's kitchen.

• The Job: The chef's main job is to make a special ingredient called Serine.
• The Problem: The bacteria lives inside your immune cells (macrophages). In this specific environment, the "pantry" is empty. There is no Serine available for the bacteria to steal; they have to make it from scratch.
• The Discovery: The scientists found that if you remove the SerC chef (by deleting the gene), the bacteria cannot make Serine. Without this ingredient, the kitchen shuts down, and the bacteria cannot grow or survive inside your body.

The Experiment: Testing the Weakness

The researchers tested this idea in three different ways, like running a burglar through three different security scenarios:

1. The Test Kitchen (Lab Cells): They put the bacteria in a petri dish with human immune cells. The bacteria without the SerC chef grew very poorly, like a plant that forgot to get water.
2. The Simulation (Mouse Model): They infected mice with the bacteria. The mice infected with the "chef-less" bacteria stayed healthy, and the bacteria population in their lungs crashed. The bacteria couldn't survive the real-world environment.
3. The Menu Test (Nutrient Check): They tried to feed the bacteria different foods to see if anything could save them.
   • Result: Giving them Serine or Glycine (a related ingredient) saved them. Giving them other common foods (like ammonium) did not. This proved that the bacteria specifically needed the Serine-making machine to survive.

The Domino Effect: One Missing Ingredient Breaks the Whole Factory

The most interesting part of the paper is what happened to the rest of the bacteria's body when the SerC chef was removed.

Imagine the bacteria is a massive factory. Serine isn't just one product; it's a central hub that connects many different assembly lines.

• When the Serine line stopped, the Carbon line (energy) slowed down.
• The Nitrogen line (building blocks) got clogged.
• The One-Carbon line (which helps make DNA) started running in circles, trying to compensate.

The Analogy: Think of SerC as the main power switch for a city. When you flip it off, it's not just the lights that go out; the traffic lights stop, the water pumps fail, and the internet goes down. The bacteria tried to reroute power (metabolic rewiring), but the whole system became chaotic and inefficient. They couldn't make enough energy or build enough parts to keep the "burglar" alive.

The Search for a Delivery Truck (Transporters)

The scientists also asked a second question: "If the bacteria can't make Serine, can it just steal it from us?"

They looked for a "delivery truck" (a transporter protein) that the bacteria might use to grab Serine from the human host.

• The Surprise: They couldn't find a specific truck dedicated to Serine.
• The Conclusion: It seems the bacteria relies on a redundant network—maybe it uses several different generic trucks, or maybe the specific truck is so essential that it's always on duty and can't be easily targeted.
• The Takeaway: Even if we can't find the truck, blocking the factory (SerC) is still a winning strategy because the bacteria can't get the ingredient from the host anyway.

Why This Matters: A New Weapon Against TB

Tuberculosis kills millions of people every year, and drug-resistant strains are becoming a nightmare. We need new weapons.

This paper tells us that Serine biosynthesis is a "Achilles' heel" for the TB bacteria.

• The Strategy: If we can develop a drug that acts like a "kitchen lock," stopping the SerC chef from working, the bacteria will starve and die.
• The Bonus: Because human cells make Serine differently (or have plenty of it), a drug targeting this specific bacterial chef might not hurt us, making it a safe and effective new medicine.

Summary in One Sentence

The scientists discovered that the TB bacteria relies entirely on its own internal factory to make a specific ingredient called Serine to survive inside us; if we can build a drug to shut down that factory, the bacteria will collapse, offering a promising new way to cure tuberculosis.

Technical Summary

1. Problem Statement

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading cause of death globally, exacerbated by the rise of drug-resistant strains. Current therapies are often lengthy and ineffective against resistant variants, creating an urgent need for novel therapeutic targets with new mechanisms of action.

• Metabolic Gap: While Mtb's reliance on host-derived nutrients is known, the specific roles of nitrogen metabolism and amino acid biosynthesis in intracellular survival are incompletely understood.
• Specific Gap: Previous work established that Mtb cannot access exogenous serine (Ser) within human macrophages and relies on de novo biosynthesis. The enzyme phosphoserine aminotransferase (SerC, encoded by Rv0884c) is a key step in this pathway, but its full metabolic impact, essentiality across infection models, and the genetic network supporting Ser-dependent growth had not been comprehensively mapped.

2. Methodology

The study employed a multi-omics systems biology approach combining genetics, metabolomics, fluxomics, and in vivo infection models:

• Genetic Manipulation:
  • Utilized a serC deletion mutant ($\Delta serC$) and a complemented strain ($\Delta serC::SERC$) in the H37Rv background.
  • Generated a transposon (Tn) library in Mtb to screen for genes essential for growth on serine as a sole nitrogen source.
• Infection Models:
  • In Vitro: Growth assays in primary human macrophages (derived from PBMCs) and murine RAW 264.7 macrophages.
  • In Vivo: Aerosol infection of BALB/c mice to assess bacterial burden in lungs over 28 days.
• Metabolic Flux Analysis (MFA) & Isotopic Tracing:
  • Used $^{13}$C-glycerol and $^{15}$N-ammonium chloride tracers to track carbon and nitrogen flow.
  • Quantified incorporation into proteinogenic amino acids via Gas Chromatography-Mass Spectrometry (GC-MS).
  • Performed $^{13}$C-Metabolic Flux Analysis (MFA) using the INCA platform to model central carbon metabolism (CCM) fluxes.
• Nitrogen Utilization Assays: Tested the ability of the $\Delta serC$ mutant to grow on various organic and inorganic nitrogen sources (amino acids, ammonium) in minimal media.
• Transporter Validation: Tested candidate transporters (e.g., cycA) using Tn mutants and isotopic labeling with $[^{13}C_3^{15}N_1]$-serine to verify uptake mechanisms.

3. Key Contributions

1. Validation of SerC as a Druggable Target: Confirmed that SerC is essential for Mtb survival in both macrophage and murine infection models, establishing serine biosynthesis as a critical vulnerability.
2. Metabolic Rewiring Map: Defined how the loss of SerC reprograms central carbon and nitrogen metabolism, revealing a global reduction in glycolytic and TCA cycle fluxes and a shift toward specific amino acid biosynthesis.
3. Genetic Network Identification: Identified SdaA (serine deaminase) and the Glycine Cleavage System (GCS) as critical determinants for serine-dependent nitrogen assimilation.
4. Transporter Redundancy: Demonstrated that Mtb likely utilizes a redundant network of transporters for serine uptake, as no single dedicated serine transporter was identified, challenging the assumption of a single "master" transporter.

4. Key Results

A. Essentiality and Virulence

• Intracellular Growth: The $\Delta serC$ mutant showed severe growth defects in primary human macrophages and RAW 264.7 cells. This was not due to host toxicity but bacterial metabolic insufficiency.
• In Vivo Attenuation: In BALB/c mice, the $\Delta serC$ mutant exhibited a drastic reduction in lung bacterial burden compared to Wild Type (WT) and complemented strains, confirming that de novo serine biosynthesis is indispensable for in vivo virulence.
• Rescue Specificity: Growth defects were fully rescued by exogenous Serine and Glycine, but not by Ammonium ($NH_4Cl$) or most other amino acids, confirming SerC's specific role in the serine-glycine pathway.

B. Metabolic Flux Reprogramming ($^{13}$C-MFA)

Deletion of serC caused extensive metabolic rewiring:

• Reduced Fluxes: Significant decreases in glycolytic flux (GAP to Pyruvate), TCA cycle flux, and the Methylcitrate Cycle (MCC).
• Increased Fluxes:
  • Oxidative Pentose Phosphate Pathway (PPP): Elevated to meet increased demand for NADPH and nucleotide precursors.
  • Valine Degradation: Increased flux to generate propionyl-CoA, which was diverted away from MCC (detoxification) toward cell wall lipid synthesis (e.g., PDIMs).
  • One-Carbon Metabolism: Elevated flux toward glycine and folate cycle reactions to support nucleotide and amino acid synthesis.
• Global Impact: The mutant showed reduced $^{13}$C and $^{15}$N incorporation into most amino acids (Ala, Val, Leu, His, Met, Pro), indicating a global slowdown in biomass synthesis.

C. Transposon Sequencing (Tn-Seq) Findings

• SdaA Dependence: The sdaA gene (encoding L-serine deaminase) was identified as essential for growth when serine is the sole nitrogen source. This confirms that Mtb relies on SdaA to deaminate serine into pyruvate and ammonia for nitrogen assimilation.
• Glycine Cleavage System (GCS): Genes gcvB, gcvH, and gcvT were enriched in the serine-selected library, suggesting the GCS is crucial for recycling glycine-derived one-carbon units when serine is abundant.
• Transporter Analysis: No specific serine transporter was identified. The cycA gene (annotated as a D-serine/alanine/glycine transporter) was not essential for serine utilization, as $\Delta cycA$ mutants grew normally on serine. This implies functional redundancy among multiple transporters or the use of an essential transporter absent from the library.

5. Significance and Implications

• Therapeutic Potential: The study validates SerC as a high-value drug target. Inhibiting SerC would starve Mtb of serine and glycine, collapse central metabolism, and impair virulence, particularly in the nutrient-restricted intracellular environment.
• Combination Strategies: The identification of SdaA and the GCS as co-dependent factors suggests that targeting the entire serine-glycine-one-carbon network (biosynthesis + catabolism) could prevent metabolic bypass and enhance drug efficacy.
• Metabolic Plasticity: The findings highlight Mtb's ability to rewire its metabolism (e.g., shifting from MCC to lipid synthesis) in response to metabolic stress, suggesting that future drugs must account for these adaptive fluxes.
• Host-Pathogen Interface: The research reinforces that Mtb's inability to scavenge host serine makes its de novo synthesis pathway a "Achilles' heel," offering a strategy to target the pathogen without harming the host (where serine is non-essential and abundant).

In conclusion, this work provides a comprehensive systems-level understanding of serine metabolism in Mtb, moving beyond simple gene essentiality to map the metabolic consequences of its disruption, thereby paving the way for novel anti-TB therapies targeting metabolic checkpoints.